(self.webpackChunk_N_E=self.webpackChunk_N_E||[]).push([[2820,769],{95533:function(e,t,n){Promise.resolve().then(n.bind(n,86834))},86834:function(e,t,n){"use strict";n.r(t),n.d(t,{default:function(){return k}});var i=n(57437),a=n(2265),r=n(27648),o=n(25553),s=n(49739),l=n(52901),c=n(10949),d=n(55407),h=n(29268),m=n(32238),p=n(18776),u=n(29951),g=n(96063),f=n(15530),y=n(37395),b=n(66031);let v={Legislation:{bg:"bg-blue-50 dark:bg-blue-950/30",text:"text-blue-700 dark:text-blue-300",border:"border-blue-200 dark:border-blue-800",dot:"bg-blue-500"},Court:{bg:"bg-red-50 dark:bg-red-950/30",text:"text-red-700 dark:text-red-300",border:"border-red-200 dark:border-red-800",dot:"bg-red-500"},Policy:{bg:"bg-green-50 dark:bg-green-950/30",text:"text-green-700 dark:text-green-300",border:"border-green-200 dark:border-green-800",dot:"bg-green-500"},International:{bg:"bg-purple-50 dark:bg-purple-950/30",text:"text-purple-700 dark:text-purple-300",border:"border-purple-200 dark:border-purple-800",dot:"bg-purple-500"}};function x(e){let{text:t}=e,n=t.split(/(https?:\/\/[^\s,)]+)/g);return(0,i.jsx)(i.Fragment,{children:n.map((e,t)=>/^https?:\/\//.test(e)?(0,i.jsx)("a",{href:e,target:"_blank",rel:"noopener noreferrer",className:"underline decoration-muted-foreground/50 hover:decoration-foreground transition-colors not-italic",onClick:e=>e.stopPropagation(),children:e},t):(0,i.jsx)("span",{children:e},t))})}function w(e){let{events:t}=e,[n,r]=(0,a.useState)(null);return(0,i.jsxs)("div",{className:"relative w-full",children:[(0,i.jsx)("div",{className:"flex flex-wrap gap-4 mb-8 text-xs",children:Object.entries(v).map(e=>{let[t,n]=e;return(0,i.jsxs)("div",{className:"flex items-center gap-1.5",children:[(0,i.jsx)("div",{className:"w-2.5 h-2.5 rounded-full ".concat(n.dot)}),(0,i.jsx)("span",{className:"text-muted-foreground",children:t})]},t)})}),(0,i.jsxs)("div",{className:"relative ml-4 sm:ml-6",children:[(0,i.jsx)("div",{className:"absolute left-0 top-0 bottom-0 w-0.5 bg-border"}),t.map((e,a)=>{var o;let s=null!==(o=v[e.category])&&void 0!==o?o:v.Legislation,l=n===a,c=0===a||t[a-1].year!==e.year;return(0,i.jsxs)("div",{className:"relative pl-8 pb-6 group",children:[(0,i.jsx)("div",{className:"absolute left-0 top-1.5 w-3 h-3 rounded-full border-2 border-background ".concat(s.dot," -translate-x-[5px] transition-transform group-hover:scale-125")}),c&&(0,i.jsx)("div",{className:"text-xs font-mono font-semibold text-muted-foreground mb-1",children:e.year}),(0,i.jsx)("button",{onClick:()=>r(l?null:a),"aria-expanded":l,"aria-controls":"timeline-event-".concat(a),className:"w-full text-left rounded-lg border p-3 sm:p-4 transition-all ".concat(s.border," ").concat(l?s.bg:"hover:bg-accent/50"),children:(0,i.jsxs)("div",{className:"flex items-start justify-between gap-2",children:[(0,i.jsxs)("div",{className:"flex-1",children:[(0,i.jsxs)("div",{className:"flex items-center gap-2 flex-wrap",children:[(0,i.jsx)("span",{className:"text-[10px] font-semibold uppercase tracking-wider px-1.5 py-0.5 rounded ".concat(s.bg," ").concat(s.text),children:e.category}),(0,i.jsx)("h4",{className:"text-sm font-semibold",children:e.title})]}),l&&(0,i.jsxs)("div",{id:"timeline-event-".concat(a),children:[(0,i.jsx)("p",{className:"mt-2 text-sm leading-relaxed text-foreground/80",children:e.description}),e.research&&e.research.length>0&&(0,i.jsxs)("div",{className:"mt-3 pt-3 border-t border-border/50 space-y-3",children:[(0,i.jsx)("p",{className:"text-xs font-semibold uppercase tracking-wider text-muted-foreground",children:"Research"}),e.research.map((e,t)=>(0,i.jsxs)("div",{className:"text-sm",children:[(0,i.jsx)("p",{className:"leading-relaxed text-foreground/80",children:e.summary}),(0,i.jsx)("p",{className:"mt-1 text-xs text-muted-foreground italic",children:(0,i.jsx)(x,{text:e.citation})})]},t))]})]})]}),(0,i.jsx)("div",{className:"shrink-0 text-muted-foreground text-xs mt-0.5",children:l?"−":"+"})]})})]},a)})]})]})}var A=n(45531),P=n(66437),S=n(85437),T=n(86449),j=n(24989);let C=[{year:1980,title:"Bayh-Dole Act",category:"Legislation",description:"Permitted universities and small businesses to patent federally funded inventions. Transformed university technology transfer and substantially increased academic patenting.",research:[{citation:"Jensen, R., & Thursby, M. (2001). Proofs and prototypes for sale: The licensing of university inventions. American Economic Review, 91(1), 240–259. https://doi.org/10.1257/aer.91.1.240",summary:"Most licensed university technologies are embryonic, requiring inventor cooperation for commercialization. A moral-hazard problem with inventor effort means development does not occur unless income is tied to output through royalties or equity."},{citation:"Thursby, J. G., & Thursby, M. C. (2002). Who is selling the ivory tower? Sources of growth in university licensing. Management Science, 48(1), 90–104. https://doi.org/10.1287/mnsc.48.1.90.14271",summary:"Post-Bayh-Dole growth in university licensing resulted primarily from faculty becoming more willing to engage in commercialization, rather than from a shift in underlying inventive productivity—suggesting changes in incentives and institutional infrastructure played a major role."},{citation:"Zucker, L. G., Darby, M. R., & Brewer, M. B. (1998). Intellectual human capital and the birth of U.S. biotechnology enterprises. American Economic Review, 88(1), 290–306. https://doi.org/10.1257/aer.88.1.290",summary:'The timing and location of biotech firm births was determined primarily by the presence of highly productive "star" scientists publishing genetic sequence discoveries, demonstrating that tacit knowledge transfer—not just patents—drives university-industry innovation.'},{citation:"Agrawal, A., & Henderson, R. M. (2002). Putting patents in context: Exploring knowledge transfer from MIT. Management Science, 48(1), 44–60. https://doi.org/10.1287/mnsc.48.1.44.14279",summary:"Patenting is a minority activity at MIT: most faculty estimate patents account for less than 10% of knowledge that transfers from their labs. Firms citing MIT papers are generally not the same as those citing MIT patents, suggesting patents capture only a narrow channel of university knowledge transfer."}]},{year:1980,title:"Stevenson-Wydler Act",category:"Legislation",description:"Required federal labs to actively participate in technology transfer. Created Office of Research and Technology Applications in major federal labs.",research:[{citation:"Cohen, W. M., Nelson, R. R., & Walsh, J. P. (2002). Links and impacts: The influence of public research on industrial R&D. Management Science, 48(1), 1–23. https://doi.org/10.1287/mnsc.48.1.1.14273",summary:"Public research significantly influences industrial R&D, but primarily through published papers, conferences, and informal interactions rather than patents. Only 7 of 34 industries rated patents from universities or government labs as an important channel, highlighting the limited role of formal IP in broader knowledge transfer."}]},{year:1982,title:"Federal Circuit Created",category:"Legislation",description:"Established the Court of Appeals for the Federal Circuit (CAFC) as the single appellate court for patent cases, unifying patent law and generally strengthening patent rights.",research:[{citation:"Galasso, A., & Schankerman, M. (2015). Patents and cumulative innovation: Causal evidence from the courts. The Quarterly Journal of Economics, 130(1), 317–369. https://doi.org/10.1093/qje/qju029",summary:"Exploiting random judge allocation at the Federal Circuit, patent invalidation leads to a 50% increase in follow-on citations. The effect is concentrated in computers, electronics, and medical instruments, driven by invalidation of patents owned by large patentees triggering more innovation by small firms."},{citation:"Hou, Y., Png, I. P. L., & Xiong, X. (2023). When stronger patent law reduces patenting: Empirical evidence. Strategic Management Journal, 44(4), 977–1012. https://doi.org/10.1002/smj.3464",summary:"Using the Federal Circuit’s creation as a quasi-natural experiment, businesses reduced strategic patenting by 23.3% on average—stronger legal protection makes each patent more effective, reducing demand for large portfolios."},{citation:"Hall, B. H., & Ziedonis, R. H. (2001). The patent paradox revisited: An empirical study of patenting in the U.S. semiconductor industry, 1979–1995. RAND Journal of Economics, 32(1), 101–128. https://doi.org/10.2307/2696400",summary:"Stronger patent rights ushered in by the CAFC reshaped incentives to patent in the semiconductor industry, increasing patent propensity by 10 percent per year after 1986. The strengthening of patent rights spawned “patent portfolio races” among capital-intensive firms but also facilitated entry by specialized design firms."},{citation:"Somaya, D., & McDaniel, C. A. (2012). Tribunal specialization and institutional targeting in patent enforcement. Organization Science, 23(3), 869–887. https://doi.org/10.1287/orsc.1110.0669",summary:"Firms strategically target different patent enforcement tribunals based on institutional characteristics, directly engaging with the Federal Circuit’s role as a specialized court and documenting how firms choose enforcement strategies in response to the court’s precedents."}]},{year:1984,title:"Hatch-Waxman Act",category:"Legislation",description:"Balanced generic drug entry with patent term restoration for pharma patents delayed by FDA review. Created the modern framework for pharmaceutical patent litigation.",research:[{citation:"Budish, E., Roin, B. N., & Williams, H. L. (2015). Do firms underinvest in long-term research? Evidence from cancer clinical trials. American Economic Review, 105(7), 2044–2085. https://doi.org/10.1257/aer.20131176",summary:"Fixed patent terms distort R&D investment away from long-term projects. Private research investments are skewed toward late-stage cancer treatments with shorter clinical trials and longer effective patent terms, while early-stage prevention research is underinvested."},{citation:"Acemoglu, D., & Linn, J. (2004). Market size in innovation: Theory and evidence from the pharmaceutical industry. The Quarterly Journal of Economics, 119(3), 1049–1090. https://doi.org/10.1162/0033553041502144",summary:"Potential market size has a large and significant effect on pharmaceutical innovation. Policies affecting expected market size for branded drugs—such as Hatch-Waxman’s generic entry timing—have meaningful effects on upstream innovation investment."},{citation:"Grabowski, H. G., & Vernon, J. M. (1990). A new look at the returns and risks to pharmaceutical R&D. Management Science, 36(7), 804–821. https://doi.org/10.1287/mnsc.36.7.804",summary:"Returns to pharma R&D are highly skewed—only the top 30 of 100 new drugs covered mean R&D costs. Any erosion of effective patent life through regulatory delays has outsized effects on the overall return to pharmaceutical innovation, motivating Hatch-Waxman’s patent term restoration."},{citation:"Cockburn, I. M., Lanjouw, J. O., & Schankerman, M. (2016). Patents and the global diffusion of new drugs. American Economic Review, 106(1), 136–164. https://doi.org/10.1257/aer.20141482",summary:"Longer and more extensive patent rights accelerate drug launch across countries, while price regulation delays it. Demonstrates that the duration of effective patent protection—the core concern of Hatch-Waxman—has real consequences for drug availability."},{citation:"Scott Morton, F. M. (1999). Entry decisions in the generic pharmaceutical industry. RAND Journal of Economics, 30(3), 421–440. https://doi.org/10.2307/2556056",summary:"Analyzing all generic drug approvals from 1984 to 1994 under Hatch-Waxman’s ANDA pathway, prior experience with a drug or therapeutic class significantly reduces the cost of preparing an application and increases the probability of entry—firms specialize along both scientific and marketing dimensions."}]},{year:1994,title:"TRIPS Agreement",category:"International",description:"The Agreement on Trade-Related Aspects of Intellectual Property Rights established minimum patent protection standards globally.",research:[{citation:"Branstetter, L. G., Fisman, R., & Foley, C. F. (2006). Do stronger intellectual property rights increase international technology transfer? Empirical evidence from U.S. firm-level panel data. The Quarterly Journal of Economics, 121(1), 321–349. https://doi.org/10.1093/qje/121.1.321",summary:"U.S. multinationals respond to TRIPS-related IP reforms abroad by significantly increasing technology transfer. Royalty payments to affiliates increase by over 30% for affiliates of parent companies that use U.S. patents most extensively prior to reform."},{citation:"Cockburn, I. M., Lanjouw, J. O., & Schankerman, M. (2016). Patents and the global diffusion of new drugs. American Economic Review, 106(1), 136–164. https://doi.org/10.1257/aer.20141482",summary:"Patent and price regulation regimes strongly affect how quickly new drugs become commercially available globally. Longer patent rights (as promoted by TRIPS) accelerate drug launch, highlighting TRIPS’s role in driving global pharmaceutical diffusion."},{citation:"Moser, P., & Voena, A. (2012). Compulsory licensing: Evidence from the Trading with the Enemy Act. American Economic Review, 102(1), 396–427. https://doi.org/10.1257/aer.102.1.396",summary:"Using a WWI natural experiment, compulsory licensing increased domestic invention by 20%. Directly relevant to TRIPS Article 31, which allows compulsory licenses for public health needs."},{citation:"Chaudhuri, S., Goldberg, P. K., & Jia, P. (2006). Estimating the effects of global patent protection in pharmaceuticals: A case study of quinolones in India. American Economic Review, 96(5), 1477–1514. https://doi.org/10.1257/aer.96.5.1477",summary:"Using structural demand estimation on the Indian fluoroquinolones market, the withdrawal of domestic generic products following TRIPS-mandated patent protection would cause substantial consumer welfare losses, even in the presence of price regulation—providing direct empirical evidence on the distributional consequences of TRIPS in developing countries."}]},{year:1995,title:"GATT Patent Term Change",category:"Legislation",description:"US patent term changed from 17 years from grant date to 20 years from earliest filing date, aligning with international standards.",research:[{citation:"Budish, E., Roin, B. N., & Williams, H. L. (2015). Do firms underinvest in long-term research? Evidence from cancer clinical trials. American Economic Review, 105(7), 2044–2085. https://doi.org/10.1257/aer.20131176",summary:"The shift from 17 years from grant to 20 years from filing altered effective patent life. Fixed patent terms distort R&D incentives, particularly disadvantaging long-duration projects where much of the patent term is consumed during regulatory approval."}]},{year:1998,title:"State Street Bank v. Signature Financial Group (149 F.3d 1368)",category:"Court",description:'The Court of Appeals for the Federal Circuit held that business methods are patentable if they produce a "useful, concrete, and tangible result." This holding precipitated a substantial increase in software and business method patent filings.',research:[{citation:"Cockburn, I. M., & MacGarvie, M. J. (2011). Entry and patenting in the software industry. Management Science, 57(5), 915–933. https://doi.org/10.1287/mnsc.1110.1321",summary:"A 10% increase in patents relevant to a software market reduces the entry rate by 3–8%, intensifying after expansions in software patentability during the mid-1990s. However, potential entrants holding their own patents are more likely to enter, suggesting patents serve as both barriers and entry tickets."}]},{year:1999,title:"American Inventors Protection Act",category:"Legislation",description:"Required publication of patent applications 18 months after filing (with opt-out for US-only filers). Introduced inter partes reexamination.",research:[{citation:"Hegde, D., Herkenhoff, K., & Zhu, C. (2023). Patent publication and innovation. Journal of Political Economy, 131(7), 1845–1903. https://doi.org/10.1086/723636",summary:"Exploiting the AIPA’s 18-month publication mandate as a natural experiment, US patents received more and faster follow-on citations, technological overlap increased between distant but related patents, and firms exposed to longer grant delays increased R&D by 4%."},{citation:"Hegde, D., & Luo, H. (2018). Patent publication and the market for ideas. Management Science, 64(2), 652–672. https://doi.org/10.1287/mnsc.2016.2622",summary:"Post-AIPA biomedical patent applications were significantly more likely to be licensed before grant, with licensing delays reduced by about 10 months. Standardized disclosure mitigated information costs and facilitated the market for ideas."},{citation:"Luck, S., Balsmeier, B., Seliger, F., & Fleming, L. (2020). Early disclosure of invention and reduced duplication: An empirical test. Management Science, 66(6), 2677–2685. https://doi.org/10.1287/mnsc.2019.3521",summary:"AIPA’s early disclosure requirement reduced duplicative patent applications, which in turn reduced abandonments and similarity between closely related inventions—providing causal evidence that disclosure decreases wasteful R&D duplication."}]},{year:2003,title:"USPTO 21st Century Strategic Plan",category:"Policy",description:"USPTO launched comprehensive reform to address growing patent backlog and pendency concerns.",research:[{citation:"Hegde, D., Ljungqvist, A., & Raj, M. (2022). Quick or broad patents? Evidence from U.S. startups. The Review of Financial Studies, 35(6), 2705–2742. https://doi.org/10.1093/rfs/hhab097",summary:"Using quasi-random assignment of patent applications to examiners, grant delays reduce a startup’s employment growth, sales growth, survival chances, and access to external capital. Patent pendency imposes substantial costs on the innovation ecosystem."},{citation:"Gans, J. S., Hsu, D. H., & Stern, S. (2008). The impact of uncertain intellectual property rights on the market for ideas: Evidence from patent grant delays. Management Science, 54(5), 982–997. https://doi.org/10.1287/mnsc.1070.0814",summary:"The hazard rate for achieving a cooperative licensing agreement increases significantly upon formal patent grant, suggesting that patent pendency creates real frictions in the market for ideas—a key motivation for USPTO reforms."}]},{year:2006,title:"eBay v. MercExchange (547 U.S. 388)",category:"Court",description:"The Court held that patent holders are not automatically entitled to injunctive relief, ending the presumption of permanent injunctions in patent cases. This holding substantially affected non-practicing entity (NPE) litigation strategies.",research:[{citation:"Mezzanotti, F. (2021). Roadblock to innovation: The role of patent litigation in corporate R&D. Management Science, 67(12), 7362–7390. https://doi.org/10.1287/mnsc.2020.3816",summary:"Exploiting the eBay decision as a natural experiment, the ruling led to a general increase in innovation by reducing distortions caused by patent litigation. Patent litigation negatively affects R&D investment by lowering returns and exacerbating financing constraints."},{citation:"Aydin Ozden, S., & Khashabi, P. (2023). Patent remedies and technology licensing: Evidence from a supreme court decision. Strategic Management Journal, 44(9), 2311–2338. https://doi.org/10.1002/smj.3493",summary:"The eBay decision reduced U.S. firms’ propensity to license, driven mainly by small firms in discrete technology industries. Injunctions serve as a credible threat that enhances licensor bargaining power."},{citation:"Cohen, L., Gurun, U. G., & Kominers, S. D. (2019). Patent trolls: Evidence from targeted firms. Management Science, 65(12), 5461–5486. https://doi.org/10.1287/mnsc.2018.3147",summary:"NPEs target cash-rich firms, asserting lower-quality patents and engaging in forum shopping. NPE litigation significantly reduces innovation at targeted firms—the hold-up concerns that motivated the eBay ruling."},{citation:"Farrell, J., & Shapiro, C. (2008). How strong are weak patents? American Economic Review, 98(4), 1347–1369. https://doi.org/10.1257/aer.98.4.1347",summary:"When downstream users compete, even probabilistic (weak) patents can extract high running royalties. Examining patent validity prior to licensing is socially beneficial both ex post and ex ante—providing the theoretical foundation for why reducing automatic injunctions, as the eBay ruling accomplished, can improve welfare."}]},{year:2007,title:"KSR v. Teleflex (550 U.S. 398)",category:"Court",description:'The Court held that the rigid "teaching-suggestion-motivation" test previously employed by the Federal Circuit was not the exclusive standard for obviousness under 35 U.S.C. \xa7 103, thereby broadening the grounds for patent invalidation.',research:[{citation:"Schankerman, M., & Schuett, F. (2022). Patent screening, innovation, and welfare. The Review of Economic Studies, 89(4), 2101–2148. https://doi.org/10.1093/restud/rdab073",summary:"Almost half of all issued patents are on inventions that do not require the patent incentive. Raising examination intensity (making the obviousness standard stricter, as KSR did) significantly improves welfare, according to simulations calibrated on U.S. data."}]},{year:2010,title:"Bilski v. Kappos (561 U.S. 593)",category:"Court",description:'The Court held that the "machine-or-transformation" test is not the sole test for patent eligibility under 35 U.S.C. \xa7 101, while narrowing the scope of patentable subject matter for business methods. No empirical study of this provision’s effects has been identified in a leading peer-reviewed journal.',research:[]},{year:2011,title:"America Invents Act (AIA)",category:"Legislation",description:'The most comprehensive patent reform since the Patent Act of 1952. Transitioned the United States from a "first to invent" to a "first inventor to file" system. Established inter partes review (IPR) and post-grant review (PGR) proceedings at the Patent Trial and Appeal Board (PTAB).',research:[{citation:"Schankerman, M., & Schuett, F. (2022). Patent screening, innovation, and welfare. The Review of Economic Studies, 89(4), 2101–2148. https://doi.org/10.1093/restud/rdab073",summary:"Screening is highly imperfect, with almost half of all patents issued on inventions that do not require the patent incentive. The introduction of cheaper validity challenge mechanisms like PTAB results in welfare increases of 0.8%."},{citation:"Gaessler, F., Harhoff, D., Sorg, S., & von Graevenitz, G. (2025). Patents, freedom to operate, and follow-on innovation: Evidence from post-grant opposition. Management Science, 71(2), 1315–1334. https://doi.org/10.1287/mnsc.2019.02294",summary:"Patent invalidation through post-grant opposition increases follow-on innovation by 16% on average. Provides directly applicable evidence for evaluating the AIA’s IPR and post-grant review proceedings, which serve analogous functions."},{citation:"Cohen, L., Gurun, U. G., & Kominers, S. D. (2019). Patent trolls: Evidence from targeted firms. Management Science, 65(12), 5461–5486. https://doi.org/10.1287/mnsc.2018.3147",summary:"NPE litigation causes real harm to innovation at targeted firms, providing the economic justification for the AIA’s inter partes review as a lower-cost alternative to district court litigation."},{citation:"Huang, K. G., Li, M.-X., Shen, C. H.-H., & Wang, Y. (2024). Escaping the patent trolls: The impact of non-practicing entity litigation on firm innovation strategies. Strategic Management Journal, 45(10), 1954–1987. https://doi.org/10.1002/smj.3606",summary:"Firms targeted by NPEs shift toward in-house technologies to reduce legal exposure, while non-target firms redirect innovation away from targeted areas. These distortions underscore why the AIA introduced IPR proceedings."},{citation:"Helmers, C., & Love, B. J. (2023). Patent validity and litigation: Evidence from US inter partes review. Journal of Law & Economics, 66(1), 53–81. https://doi.org/10.1086/721911",summary:"Analyzing the AIA’s inter partes review mechanism directly, both the decision to file an IPR petition and the PTAB’s initial institution decision have large, positive effects on the settlement rate of concurrent court proceedings—demonstrating that IPR generates valuable validity information that facilitates case resolution."}]},{year:2013,title:"AIA First-Inventor-to-File",category:"Policy",description:"The AIA's first-inventor-to-file provision took effect March 16, 2013, fundamentally changing patent priority rules. No empirical study of this provision’s effects has been identified in a leading peer-reviewed journal.",research:[]},{year:2013,title:"Association for Molecular Pathology v. Myriad (569 U.S. 576)",category:"Court",description:"The Court held that naturally occurring DNA segments are not patent-eligible under 35 U.S.C. \xa7 101, but that synthetically created complementary DNA (cDNA) is patent-eligible. This holding had substantial implications for biotechnology patenting.",research:[{citation:"Sampat, B. N., & Williams, H. L. (2019). How do patents affect follow-on innovation? Evidence from the human genome. American Economic Review, 109(1), 203–236. https://doi.org/10.1257/aer.20151398",summary:"While patented genes appear more valuable prior to being patented, two quasi-experimental approaches suggest that gene patents had no quantitatively important effect on follow-on innovation on average."},{citation:"Williams, H. L. (2013). Intellectual property rights and innovation: Evidence from the human genome. Journal of Political Economy, 121(1), 1–27. https://doi.org/10.1086/669706",summary:"Celera’s short-term IP on gene sequences led to 20–30% reductions in subsequent scientific research and product development, with negative effects persisting even after the IP was removed."},{citation:"Huang, K. G., & Murray, F. E. (2009). Does patent strategy shape the long-run supply of public knowledge? Evidence from human genetics. Academy of Management Journal, 52(6), 1193–1221. https://doi.org/10.5465/amj.2009.47084665",summary:"Gene patents decrease public genetic knowledge, with broader scope, private sector ownership, and commercial relevance exacerbating the effect—directly documenting the innovation costs that the Myriad decision addressed."}]},{year:2014,title:"Alice Corp. v. CLS Bank International (573 U.S. 208)",category:"Court",description:"The Court held that claims directed to an abstract idea implemented on a generic computer are not patent-eligible under 35 U.S.C. \xa7 101, establishing a two-step framework for patent eligibility analysis. This holding led to a substantial increase in \xa7 101 rejections and invalidations, particularly for software patents.",research:[{citation:"Schankerman, M., & Schuett, F. (2022). Patent screening, innovation, and welfare. The Review of Economic Studies, 89(4), 2101–2148. https://doi.org/10.1093/restud/rdab073",summary:"Nearly half of issued patents are on inventions that do not require patent incentives. Improving screening (which the Alice Corp. holding effectively accomplished for software patents) can significantly improve welfare."},{citation:"Mezzanotti, F. (2021). Roadblock to innovation: The role of patent litigation in corporate R&D. Management Science, 67(12), 7362–7390. https://doi.org/10.1287/mnsc.2020.3816",summary:"Patent litigation deters R&D investment by lowering returns and exacerbating financing constraints. The overly broad software patents addressed by the Alice Corp. holding were a significant source of such litigation-driven innovation costs."}]},{year:2017,title:"TC Heartland v. Kraft Foods (581 U.S. 258)",category:"Court",description:"The Court held that patent infringement suits must be filed where the defendant is incorporated, restricting venue rules. This holding substantially reduced filings in the previously plaintiff-favorable Eastern District of Texas.",research:[{citation:"Cohen, L., Gurun, U. G., & Kominers, S. D. (2019). Patent trolls: Evidence from targeted firms. Management Science, 65(12), 5461–5486. https://doi.org/10.1287/mnsc.2018.3147",summary:"Documents NPE forum shopping as a key element of strategic assertion-entity litigation, with the Eastern District of Texas as a favored venue. TC Heartland directly curtailed this behavior by restricting patent venue."},{citation:"Mezzanotti, F. (2021). Roadblock to innovation: The role of patent litigation in corporate R&D. Management Science, 67(12), 7362–7390. https://doi.org/10.1287/mnsc.2020.3816",summary:"Patent litigation negatively affects R&D investment. Venue reforms that reduce litigation costs and forum-shopping incentives—such as TC Heartland—can increase innovation by lowering enforcement distortions."}]},{year:2018,title:"Oil States v. Greene's Energy (584 U.S. 325)",category:"Court",description:"The Court held that inter partes review (IPR) proceedings at the PTAB are constitutional, affirming Congress's authority to create administrative patent validity challenges.",research:[{citation:"Schankerman, M., & Schuett, F. (2022). Patent screening, innovation, and welfare. The Review of Economic Studies, 89(4), 2101–2148. https://doi.org/10.1093/restud/rdab073",summary:"Courts alone cannot solve the patent screening problem. Administrative patent validity mechanisms like IPR—whose constitutionality Oil States upheld—generate welfare improvements by providing a cheaper alternative to litigation for challenging weak patents."}]},{year:2018,title:"SAS Institute v. Iancu (584 U.S. 357)",category:"Court",description:"The Court held that the PTAB must review all claims challenged in an IPR petition, not merely a subset, thereby altering PTAB practice."},{year:2021,title:"Executive Order on Competition",category:"Policy",description:"The Executive Order on Promoting Competition directed federal agencies to address the misuse of patents and strengthened patent system transparency initiatives.",research:[{citation:"Lerner, J., & Tirole, J. (2015). Standard-essential patents. Journal of Political Economy, 123(3), 547–586. https://doi.org/10.1086/680995",summary:"Patents that become standard-essential create inefficiencies from lack of price commitments. Structured commitments can restore competition—providing the economic foundation for the Executive Order’s directive to reconsider policies on standard-essential patents and FRAND commitments."}]},{year:2025,title:"Proposed PREVAIL Act & Patent Eligibility Restoration Act (PERA)",category:"Legislation",description:"PREVAIL Act (S.1553) and Patent Eligibility Restoration Act (S.1546) were reintroduced in the 119th Congress. These proposals would reform the PTAB system and patent eligibility under 35 U.S.C. \xa7 101, reflecting the ongoing policy debate regarding the balance of innovation incentives. As of 2025, both bills remain under committee consideration and have not been enacted."}];function k(){let{data:e,loading:t}=(0,o.k)("chapter10/applications_vs_grants.json"),{data:n,loading:v}=(0,o.k)("chapter10/alice_event_study.json"),{data:x,loading:k}=(0,o.k)("chapter6/alice_art_group_indexed.json"),{data:E,loading:M}=(0,o.k)("chapter6/alice_art_group_pendency.json"),{data:I,loading:R}=(0,o.k)("chapter6/terminal_disclaimer_rate.json"),{data:F,loading:_}=(0,o.k)("chapter6/terminal_disclaimer_by_cpc.json"),{data:D,loading:L}=(0,o.k)("chapter6/patent_term_adjustment.json"),{data:N,loading:U}=(0,o.k)("chapter6/pta_by_cpc_section.json"),B=(0,a.useMemo)(()=>e?e.filter(e=>e.year<=2024):[],[e]),z=(0,a.useMemo)(()=>n?[...new Set(n.map(e=>e.year))].sort().map(e=>{var t,i,a,r;let o=n.find(t=>t.year===e&&t.group_label.startsWith("Software")),s=n.find(t=>t.year===e&&t.group_label.startsWith("Control"));return{year:e,sw_idx_count:null!==(t=null==o?void 0:o.idx_count)&&void 0!==t?t:null,sw_idx_claims:null!==(i=null==o?void 0:o.idx_claims)&&void 0!==i?i:null,ctrl_idx_count:null!==(a=null==s?void 0:s.idx_count)&&void 0!==a?a:null,ctrl_idx_claims:null!==(r=null==s?void 0:s.idx_claims)&&void 0!==r?r:null}}):[],[n]),H=(0,a.useMemo)(()=>x?[...new Set(x.map(e=>e.year))].sort().map(e=>{let t={year:e};return x.filter(t=>t.year===e).forEach(e=>{"treatment"===e.group_type&&(t.treatment_indexed=e.indexed),"control"===e.group_type&&(t.control_indexed=e.indexed)}),t}):[],[x]),G=(0,a.useMemo)(()=>E?[...new Set(E.map(e=>e.year))].sort().map(e=>{let t={year:e};return E.filter(t=>t.year===e).forEach(e=>{"treatment"===e.group_type&&(t.treatment_pendency=e.median_pendency_days),"control"===e.group_type&&(t.control_pendency=e.median_pendency_days)}),t}):[],[E]),O=(0,a.useMemo)(()=>I?I.filter(e=>e.year<=2024):[],[I]),Z=(0,a.useMemo)(()=>N?[...N].sort((e,t)=>t.median_pta_days-e.median_pta_days):[],[N]),q=(0,a.useMemo)(()=>F?[...F].sort((e,t)=>t.td_rate_pct-e.td_rate_pct):[],[F]);return(0,i.jsxs)("div",{children:[(0,i.jsx)(s.K,{number:6,title:"Patent Law & Policy",subtitle:"Legislation and jurisprudence shaping the patent system"}),(0,i.jsx)(l.x,{slug:"system-patent-law"}),(0,i.jsxs)(A.u,{children:[(0,i.jsxs)("li",{children:["The ",(0,i.jsx)(S.h,{term:"Bayh-Dole Act",children:"Bayh-Dole Act"})," (1980) transformed university patenting, enabling academic institutions to retain patent rights from federally funded research."]}),(0,i.jsx)("li",{children:"The America Invents Act (2011) constituted the most significant patent reform since 1952, transitioning the United States from a first-to-invent to a first-inventor-to-file system."}),(0,i.jsxs)("li",{children:["In ",(0,i.jsx)(S.h,{term:"Alice decision",children:"Alice Corp. v. CLS Bank International"})," (2014), the Court held that abstract ideas implemented on generic computers are not patent-eligible under 35 U.S.C. \xa7 101, substantially curtailing patent eligibility for software and business method patents."]}),(0,i.jsx)("li",{children:"Legislative and judicial changes are associated with observable shifts in patent filing patterns, with changes appearing in the data within one to two years of major rulings."})]}),(0,i.jsxs)("aside",{className:"my-8 rounded-lg border bg-muted/30 p-5",children:[(0,i.jsx)("h2",{className:"mb-2 text-sm font-semibold uppercase tracking-wide text-muted-foreground",children:"Executive Summary"}),(0,i.jsxs)("p",{className:"text-sm leading-relaxed",children:["A half-century of patent law reveals two broad regulatory phases: an era of expansion from the early 1980s through 2000 -- during which university patenting, strengthened enforcement, and broadened subject-matter eligibility coincided with the volume growth documented in ",(0,i.jsx)(r.default,{href:"/chapters/system-patent-count/",className:"underline decoration-muted-foreground/50 hover:decoration-foreground transition-colors",children:"the preceding chapters"})," -- followed by an era of recalibration in which the Supreme Court narrowed eligibility doctrine and Congress introduced lower-cost administrative validity challenges at the PTAB. The data are consistent with these legal shifts producing observable changes in patent filing patterns within one to two years of enactment: the already-rising trend in applications around the 1998 State Street decision, pendency declines after AIA-era reforms, and a potential moderation in software-related patenting following the 2014 Alice eligibility restriction."]})]}),(0,i.jsx)(c.n,{children:(0,i.jsxs)("p",{children:["The patent system operates within a dynamic legal and institutional context. Over the past half century,"," ",(0,i.jsx)(d._,{value:"landmark legislation"}),", Supreme Court decisions, and policy changes have fundamentally reshaped the rules governing patents -- who may obtain them, what subject matter is patent-eligible, and how patents may be enforced. These legal shifts have had substantial effects on patenting behavior, with observable impacts on the trends documented throughout this book."]})}),(0,i.jsx)(c.n,{children:(0,i.jsx)("p",{children:"The timeline below chronicles the most consequential changes to United States patent law and policy from 1980 to the present. Each event entry includes a description of its impact and references to published academic research examining its effects."})}),(0,i.jsx)("div",{className:"my-10",children:(0,i.jsx)(w,{events:C})}),(0,i.jsx)(y.c,{children:(0,i.jsxs)("p",{children:["The trajectory of patent law over the past four decades exhibits a discernible pattern: an era of expansion and strengthening (1982-2000) shaped by the Court of Appeals for the Federal Circuit and pro-patent legislative reforms, followed by an era of recalibration (2006-present) as the Supreme Court narrowed patent scope, and Congress established administrative alternatives to costly litigation through the ",(0,i.jsx)(S.h,{term:"AIA",children:"AIA"}),"."]})}),(0,i.jsx)(f.d,{label:"Impact on Patent Activity"}),(0,i.jsxs)(c.n,{children:[(0,i.jsx)("p",{children:"Several of the legal events documented above exhibit observable effects on the patent data examined in earlier chapters:"}),(0,i.jsxs)("ul",{className:"list-disc pl-5 space-y-2 mt-2",children:[(0,i.jsxs)("li",{children:[(0,i.jsx)("strong",{children:"Bayh-Dole Act (1980):"})," Coincided with a substantial increase in university patenting, though scholars debate whether the Act catalyzed the trend or formalized an existing one. Government-funded patents (Public Investment) began rising in the 1980s as universities established technology transfer offices."]}),(0,i.jsxs)("li",{children:[(0,i.jsx)("strong",{children:"Court of Appeals for the Federal Circuit (1982):"})," Unified and strengthened patent rights, a change widely cited as a factor in the upward trend in patent grants through the 1990s and 2000s (Patent Count)."]}),(0,i.jsxs)("li",{children:[(0,i.jsx)("strong",{children:"State Street Bank v. Signature Financial Group (1998):"})," Established the patentability of business methods, The subsequent acceleration in software patent filings is consistent with this ruling, observable as the acceleration of Section G (Physics) and H (Electricity) patents in the late 1990s (Patent Fields)."]}),(0,i.jsxs)("li",{children:[(0,i.jsx)("strong",{children:"America Invents Act (2011):"})," Created the PTAB inter partes review system, providing a faster and cheaper alternative to litigation for challenging patent validity. The shift to first-inventor-to-file changed priority rules for all patents filed after March 2013."]}),(0,i.jsxs)("li",{children:[(0,i.jsx)("strong",{children:"Alice Corp. v. CLS Bank International (2014):"})," The Court held that abstract ideas implemented on generic computers are not patent-eligible under 35 U.S.C. \xa7 101, substantially narrowing patent eligibility. This holding may have contributed to a moderation in software-related patenting in subsequent years, though Sections G and H continued to grow in absolute terms."]})]})]}),(0,i.jsx)(y.c,{children:(0,i.jsx)("p",{children:"The patent system reflects a persistent tension between encouraging innovation through strong patent rights and preventing the misuse of overly broad patents that may impede competition. Each major legal change represents a recalibration of this balance, with measurable consequences for the pace, direction, and character of patenting activity."})}),(0,i.jsx)(f.d,{label:"The Patent Pipeline"}),(0,i.jsx)(c.n,{children:(0,i.jsx)("p",{children:"The efficiency of the patent system in processing inventions warrants examination. Comparing the number of patent applications filed each year against the grants issued enables tracking of the USPTO's throughput and the growing gap between filing and granting activity. The ratio of grants to applications indicates how the system's selectivity and backlog have evolved over time."})}),(0,i.jsx)(p.B,{id:"fig-patent-law-applications-vs-grants",subtitle:"Annual patent applications (by filing date) and grants (by grant date) with the grant-to-application ratio, tracking USPTO throughput over time.",title:"Successfully Granted Applications Grew from 66,000 (Average, 1976–1979) to 349,000 (2019) While the Grant-to-Application Ratio Fell from Over 100% in the Mid-1970s to 66% by 1997, Reflecting Increasing Examination Lag",caption:"The figure displays annual filings (by filing date) and grants (by grant date) for utility patents, with the grant-to-application ratio. Only patents that were eventually granted appear in this dataset. The growing gap between applications and grants since the mid-1990s reflects the increasing duration between filing and grant.",insight:"Major legislative changes coincide with observable inflection points in patent filing data, consistent with a relationship between policy and innovation incentives. The growing gap between applications and grants is consistent with increasing examination complexity and backlog.",loading:t,children:(0,i.jsx)(u.J,{data:B,xKey:"year",lines:[{key:"applications",name:"Applications (filing date)",color:"#0072B2"},{key:"grants",name:"Grants (grant date)",color:"#009E73"},{key:"grant_to_application_ratio",name:"Grant/Application Ratio (%)",color:"#E69F00",yAxisId:"right"}],yLabel:"Number of Patents",rightYLabel:"Ratio (%)",rightYFormatter:e=>"".concat(e.toFixed(0),"%"),referenceLines:(0,T.kM)(T.Ik)})}),(0,i.jsx)(y.c,{children:(0,i.jsx)("p",{children:"In the early years, grants and applications tracked closely because the dataset only captures successful filings. The growing divergence from the mid-1990s onward reflects the increasing time lag between filing and grant; applications filed in a given year may not be granted for two to four years. The increase in grants around 2012-2015 coincides with the USPTO clearing a significant backlog, while the America Invents Act's procedural reforms reshaped the pipeline."})}),(0,i.jsx)(p.B,{id:"fig-alice-event-study",title:"Alice Corp. Did Not Halt Software Patent Growth",subtitle:"Patent count and mean claims indexed to 2013 = 100: software patents versus control group, 2008–2020",loading:v,children:(0,i.jsx)(u.J,{data:z,xKey:"year",lines:[{key:"sw_idx_count",name:"Software — Patent Count",color:j.ZE[0]},{key:"ctrl_idx_count",name:"Control — Patent Count",color:j.ZE[2]},{key:"sw_idx_claims",name:"Software — Claims",color:j.ZE[3],dashPattern:"8 4"},{key:"ctrl_idx_claims",name:"Control — Claims",color:j.ZE[5],dashPattern:"4 4"}],yLabel:"Index (2013 = 100)",referenceLines:[{x:2014,label:"Alice Corp. v. CLS Bank"}]})}),(0,i.jsx)(f.d,{label:"Alice Impact by Art Group"}),(0,i.jsx)(c.n,{children:(0,i.jsx)("p",{children:"The Alice Corp. decision (2014) restricted patent eligibility for abstract ideas implemented on generic computers, disproportionately affecting certain USPTO art groups. To assess the impact more precisely, this section compares patent grants and examination pendency for Alice-affected art groups (treatment) against unaffected art groups (control), with values indexed to 2013 = 100 to facilitate comparison."})}),(0,i.jsx)(p.B,{id:"fig-patent-law-alice-indexed",title:"Alice-Affected Art Groups Continued Growing Post-2014, Reaching 129.2 by 2024 versus 102.7 for Controls",subtitle:"Patent grants indexed to 2013 = 100 for Alice-affected (treatment) and unaffected (control) art groups, 2008-2024",caption:"Patent grant counts indexed to 2013 = 100 for USPTO art groups most affected by Alice Corp. v. CLS Bank (treatment) and unaffected art groups (control). The vertical reference line marks the 2014 Alice decision. Despite the eligibility restriction, treatment groups continued to grow, suggesting that the decision moderated but did not reverse the trend.",insight:"The Alice decision did not produce a sharp decline in patent grants for affected art groups. Instead, treatment group grants continued to outpace controls, reaching 129.2 (indexed) by 2024 compared to 102.7 for controls, suggesting that applicants adapted their claims to survive Section 101 scrutiny.",loading:k,children:H.length>0?(0,i.jsx)(u.J,{data:H,xKey:"year",lines:[{key:"treatment_indexed",name:"Treatment (Alice-Affected)",color:j.ZE[0]},{key:"control_indexed",name:"Control (Unaffected)",color:j.ZE[2]}],yLabel:"Index (2013 = 100)",referenceLines:[{x:2014,label:"Alice Decision"}]}):(0,i.jsx)("div",{})}),(0,i.jsx)(p.B,{id:"fig-patent-law-alice-pendency",title:"Pendency Declined Faster for Alice-Affected Art Groups, Falling to 978 Median Days by 2023 versus 1,114 for Controls",subtitle:"Median examination pendency in days for Alice-affected (treatment) and unaffected (control) art groups, 2008-2024",caption:"Median pendency (days from filing to grant) for Alice-affected and control art groups. Both groups experienced declining pendency over the period, but the treatment group declined more steeply, potentially reflecting faster resolution of Section 101 issues during prosecution.",insight:"The faster pendency decline in Alice-affected art groups suggests that the Alice framework, while initially disruptive, may have streamlined examination by providing clearer grounds for eligibility determinations.",loading:M,children:G.length>0?(0,i.jsx)(u.J,{data:G,xKey:"year",lines:[{key:"treatment_pendency",name:"Treatment (Alice-Affected)",color:j.ZE[0]},{key:"control_pendency",name:"Control (Unaffected)",color:j.ZE[2]}],yLabel:"Median Pendency (Days)",referenceLines:[{x:2014,label:"Alice Decision"}]}):(0,i.jsx)("div",{})}),(0,i.jsx)(y.c,{children:(0,i.jsx)("p",{children:"The art-group-level analysis reveals a nuanced picture of Alice's impact. While the decision imposed a meaningful eligibility constraint, patent grants in affected art groups continued to grow -- applicants adapted their claims and prosecution strategies. Meanwhile, examination pendency declined faster in treatment groups (from 1,267 median days in 2009 to 978 in 2023) compared to controls (from 1,440 to 1,114), suggesting that the Alice framework may have streamlined examination by providing clearer eligibility criteria."})}),(0,i.jsx)(f.d,{label:"Terminal Disclaimers"}),(0,i.jsx)(c.n,{children:(0,i.jsxs)("p",{children:["A ",(0,i.jsx)(S.h,{term:"terminal disclaimer",children:"terminal disclaimer"})," is a mechanism by which a patent owner voluntarily limits the patent's enforceable life to match that of a related patent, typically filed to overcome a double-patenting rejection. The rate of terminal disclaimer usage provides insight into patent portfolio strategy: higher rates suggest more intensive efforts to obtain overlapping patent claims on related inventions."]})}),(0,i.jsx)(p.B,{id:"fig-patent-law-td-rate",title:"Terminal Disclaimer Rate Peaked at 11.3% in 2023, Rising from Near Zero in the Late 1990s",subtitle:"Share of granted patents with a terminal disclaimer by grant year, 1976-2024",caption:"Terminal disclaimer rate computed as the percentage of granted patents that include a terminal disclaimer. The rate dropped sharply in the late 1990s (coinciding with the GATT patent term change) before rebounding and rising to record levels in the 2010s-2020s, consistent with the growth of continuation and patent family strategies.",insight:"The secular rise in terminal disclaimer rates since the early 2000s is consistent with the increasing use of continuation applications and patent family strategies, as firms seek to maintain overlapping patent protection across related inventions.",loading:R,children:O.length>0?(0,i.jsx)(u.J,{data:O,xKey:"year",lines:[{key:"td_rate_pct",name:"Terminal Disclaimer Rate (%)",color:j.ZE[0]}],yLabel:"Terminal Disclaimer Rate (%)",yFormatter:e=>"".concat(e.toFixed(1),"%")}):(0,i.jsx)("div",{})}),(0,i.jsx)(p.B,{id:"fig-patent-law-td-by-cpc",title:"H (Electricity) and C (Chemistry) Lead Terminal Disclaimer Rates at 9.2% and 8.6%",subtitle:"Terminal disclaimer rate by CPC section for patents granted 2015-2024, showing technology-specific variation in portfolio strategy",caption:"Terminal disclaimer rates by CPC section. Electricity (H) and Chemistry (C) lead, consistent with the intense patent portfolio strategies employed in semiconductors, telecommunications, and pharmaceuticals. Mechanical engineering fields (B, F) exhibit the lowest rates.",insight:"The technology-specific variation in terminal disclaimer rates reflects different patent strategies: electronics and pharmaceutical firms employ continuation-based portfolio building more aggressively than firms in mechanical engineering domains.",loading:_,children:q.length>0?(0,i.jsx)(g.o,{data:q,xKey:"cpc_section",bars:[{key:"td_rate_pct",name:"Terminal Disclaimer Rate (%)",color:j.ZE[1]}],layout:"vertical",yLabel:"Terminal Disclaimer Rate (%)",yFormatter:e=>"".concat(e.toFixed(1),"%")}):(0,i.jsx)("div",{})}),(0,i.jsx)(y.c,{children:(0,i.jsx)("p",{children:"Terminal disclaimer usage varies substantially by technology area. Section H (Electricity) and Section C (Chemistry) lead at 9.2% and 8.6% respectively, reflecting the aggressive patent portfolio strategies characteristic of semiconductor, telecommunications, and pharmaceutical firms. Section B (Operations/Transport) and Section F (Mechanical Engineering) have the lowest rates at 3.6% and 3.9%, consistent with simpler patent family structures in these domains."})}),(0,i.jsx)(f.d,{label:"Patent Term Adjustment"}),(0,i.jsx)(c.n,{children:(0,i.jsxs)("p",{children:["When the USPTO delays in examining a patent application beyond statutory deadlines, the patent term is extended through ",(0,i.jsx)(d._,{value:"Patent Term Adjustment (PTA)"}),". The median PTA provides a measure of examination delay beyond what the statute envisions as timely processing. Tracking PTA over time reveals the USPTO's evolving capacity to meet statutory examination timelines."]})}),(0,i.jsx)(p.B,{id:"fig-patent-law-pta-over-time",title:"Median Patent Term Adjustment Peaked at 520 Days in 2011, Declining to 147 Days by 2025",subtitle:"Median patent term adjustment in days by grant year, 2002-2025, tracking USPTO examination delays",caption:"Median PTA in days for granted patents by year. PTA increased substantially through the 2000s as the USPTO backlog grew, peaking at 520 days in 2011. Subsequent reforms and hiring initiatives were followed by a sustained decline, though PTA remains well above zero, indicating ongoing examination delays beyond statutory timelines.",insight:"The rise and fall of median PTA mirrors the USPTO backlog crisis and subsequent reforms. The peak of 520 days in 2011 represents nearly 1.5 years of additional patent life granted as compensation for examination delays.",loading:L,children:D&&D.length>0?(0,i.jsx)(u.J,{data:D,xKey:"year",lines:[{key:"median_pta_days",name:"Median PTA (Days)",color:j.ZE[0]}],yLabel:"Median PTA (Days)",yFormatter:e=>"".concat(Math.round(e))}):(0,i.jsx)("div",{})}),(0,i.jsx)(p.B,{id:"fig-patent-law-pta-by-cpc",title:"Section A (Human Necessities) Receives the Longest PTA at 237 Median Days",subtitle:"Median patent term adjustment in days by CPC section for patents granted 2002-2025, revealing technology-specific examination delays",caption:"Median PTA by CPC section. Human Necessities (A), which includes pharmaceuticals and biotechnology, experiences the longest delays at 237 median days, consistent with the complex examination requirements in these domains. Mechanical Engineering (F) and Electricity (H) receive the shortest adjustments.",insight:"The technology-specific variation in PTA is consistent with differential examination complexity: pharmaceutical and biotechnology patents require more specialized review and face longer pendency, while mechanical and electrical patents benefit from more established examination practices.",loading:U,children:Z.length>0?(0,i.jsx)(g.o,{data:Z,xKey:"cpc_section",bars:[{key:"median_pta_days",name:"Median PTA (Days)",color:j.ZE[4]}],layout:"vertical",yLabel:"Median PTA (Days)",yFormatter:e=>"".concat(Math.round(e))}):(0,i.jsx)("div",{})}),(0,i.jsx)(y.c,{children:(0,i.jsx)("p",{children:"Patent Term Adjustment reveals the uneven distribution of examination delays across technology domains. Section A (Human Necessities) receives a median of 237 days of additional patent term, while Section F (Mechanical Engineering) receives only 143 days. This variation has direct economic consequences: longer PTA in pharmaceuticals and biotechnology effectively extends the period of market exclusivity, with implications for both innovators and consumers."})}),(0,i.jsxs)(c.n,{children:["Having examined the legal and policy framework that governs the patent system, the analysis turns to the role of public investment in driving innovation. The ",(0,i.jsx)(r.default,{href:"/chapters/system-public-investment/",className:"underline decoration-muted-foreground/50 hover:decoration-foreground transition-colors",children:"following chapter"})," investigates how government funding and public research expenditures have shaped patenting activity, and what the evolving relationship between federal investment and patent output reveals about the foundations of the innovation ecosystem."]}),(0,i.jsx)(m.n,{learned:["Twenty-one major legislative acts, Supreme Court decisions, and policy changes from the Bayh-Dole Act (1980) to the proposed PREVAIL Act & PERA (2025) have shaped the modern patent system.","The America Invents Act of 2011 shifted the US from first-to-invent to first-to-file and created inter partes review as a major validity challenge mechanism."],falsifiable:"If Alice Corp. (2014) materially reduced software patenting, then CPC subclasses most affected by the decision should show a discontinuous decline in patent grants relative to unaffected subclasses.",nextAnalysis:{label:"Public Investment",description:"How government funding shapes the direction and quality of patented innovation",href:"/chapters/system-public-investment"}}),(0,i.jsx)(h.V,{children:'Legal information synthesized from primary sources including congressional records, Supreme Court opinions, and the USPTO. Event descriptions focus on patent-relevant impacts. This timeline is not exhaustive and focuses on the most consequential changes affecting the US patent system. Academic research summaries draw from published studies in leading economics and management journals including the American Economic Review, Quarterly Journal of Economics, Journal of Political Economy, Review of Economic Studies, Management Science, Strategic Management Journal, and Academy of Management Journal. Applications versus grants data uses PatentsView, which only includes patents that were eventually granted -- the "applications" count therefore represents successful filings rather than total submissions to the USPTO.'}),(0,i.jsx)(P.M,{currentChapter:6}),(0,i.jsx)(b.W,{currentChapter:6})]})}},85437:function(e,t,n){"use strict";n.d(t,{h:function(){return o}});var i=n(57437),a=n(2265);let r={CPC:{term:"CPC",definition:"Cooperative Patent Classification — a hierarchical system jointly managed by the USPTO and EPO that categorizes patents by technology area (e.g., H = Electricity, G = Physics)."},"forward citations":{term:"forward citations",definition:"The number of times a patent is cited by later patents. A widely used proxy for patent impact and technological importance."},"grant lag":{term:"grant lag",definition:"The time (usually in days or years) between a patent application filing date and the date the patent is granted. Also called patent pendency."},assignee:{term:"assignee",definition:"The entity (corporation, university, government, or individual) that owns the rights to a patent."},"utility patent":{term:"utility patent",definition:"A patent granted for a new and useful process, machine, manufacture, or composition of matter. The most common patent type, representing over 90% of US grants."},"design patent":{term:"design patent",definition:"A patent granted for a new, original, and ornamental design for an article of manufacture. Protects appearance, not function."},HHI:{term:"HHI",definition:"Herfindahl-Hirschman Index — a measure of market concentration calculated as the sum of squared shares. Ranges from 0 (fragmented) to 10,000 (monopoly)."},originality:{term:"originality",definition:"A patent-level metric measuring how broadly a patent draws on prior art across different technology classes. Higher originality = more diverse knowledge sources."},generality:{term:"generality",definition:"A patent-level metric measuring how broadly a patent is cited across different technology classes. Higher generality = wider downstream influence."},"patent thicket":{term:"patent thicket",definition:"A dense web of overlapping patent rights that competitors must navigate, often used as a strategic barrier to entry."},PatentsView:{term:"PatentsView",definition:"A patent data platform supported by the USPTO that provides disambiguated inventor, assignee, and citation data for US patents."},WIPO:{term:"WIPO",definition:"World Intellectual Property Organization — a UN agency that administers international IP treaties and provides technology field classifications for patents."},"Bayh-Dole Act":{term:"Bayh-Dole Act",definition:"A 1980 US law that allowed universities and small businesses to retain patent rights from federally funded research, spurring academic patenting."},AIA:{term:"AIA",definition:"America Invents Act (2011) — the most significant reform of the US patent system since 1952, switching from first-to-invent to first-inventor-to-file."},"Alice decision":{term:"Alice decision",definition:"Alice Corp. v. CLS Bank (2014) — a Supreme Court ruling that significantly restricted patent eligibility for software and business method patents."},"topic modeling":{term:"topic modeling",definition:'A machine learning technique that discovers abstract "topics" in a collection of documents by identifying clusters of frequently co-occurring words.'},"TF-IDF":{term:"TF-IDF",definition:"Term Frequency–Inverse Document Frequency — a numerical statistic that reflects how important a word is to a document relative to a larger collection. Common words are down-weighted."},NMF:{term:"NMF",definition:"Non-negative Matrix Factorization — a matrix decomposition method used for topic modeling that produces interpretable, additive topic representations."},UMAP:{term:"UMAP",definition:"Uniform Manifold Approximation and Projection — a dimensionality reduction technique that preserves both local and global structure, used to visualize high-dimensional data in 2D."},"Shannon entropy":{term:"Shannon entropy",definition:"A measure of diversity or uncertainty in a distribution. Higher entropy means a more evenly spread portfolio across technology classes; lower entropy means concentration in fewer areas."},"Jensen-Shannon divergence":{term:"Jensen-Shannon divergence",definition:"A symmetric measure of the difference between two probability distributions. Used here to detect technology portfolio pivots by comparing a company's CPC distribution across consecutive time windows."},"cosine similarity":{term:"cosine similarity",definition:"A measure of similarity between two vectors based on the angle between them. Values range from 0 (completely different) to 1 (identical). Used to compare patent portfolio compositions between companies."},"citation half-life":{term:"citation half-life",definition:"The time it takes for a company's patents to accumulate half of their total forward citations. Shorter half-lives indicate more immediately impactful inventions; longer half-lives suggest foundational work."},"talent flow":{term:"talent flow",definition:"The movement of inventors between organizations, tracked by consecutive patent filings with different assignees. Net talent flow reveals which companies are gaining vs. losing inventive talent."},"k-means clustering":{term:"k-means clustering",definition:"An unsupervised machine learning algorithm that partitions data into k groups by minimizing within-cluster distances. Used here to classify company innovation trajectories into archetypes."},"radar chart":{term:"radar chart",definition:"A multi-dimensional chart that plots values along multiple axes radiating from a center point. Useful for comparing strategy profiles across several dimensions simultaneously."},"chord diagram":{term:"chord diagram",definition:"A circular visualization showing flows or connections between entities. Arcs represent entities; ribbons connecting them represent directed flows (e.g., citation flows between companies)."},"Sankey diagram":{term:"Sankey diagram",definition:"A flow diagram where the width of links is proportional to the quantity of flow. Used here to visualize inventor talent flows between companies."},Y02:{term:"Y02",definition:"A CPC classification section for technologies related to climate change mitigation. Sub-categories include renewable energy (Y02E), transportation (Y02T), carbon capture (Y02C), buildings (Y02B), and industrial production (Y02P)."},"green patents":{term:"green patents",definition:"Patents classified under CPC codes Y02 (climate change mitigation) or Y04S (smart grids), covering technologies from solar and wind energy to electric vehicles and carbon capture."},"WIPO technology fields":{term:"WIPO technology fields",definition:"A classification of patents into 35 technology fields grouped into 5 sectors: Electrical engineering, Instruments, Chemistry, Mechanical engineering, and Other fields."},"blockbuster rate":{term:"blockbuster rate",definition:"The share of an entity's patents that fall in the top 1% of forward citations within their grant-year \xd7 CPC section cohort. Rates above 1% indicate disproportionate high-impact output."},"dud rate":{term:"dud rate",definition:"The share of an entity's patents that receive zero forward citations within five years of grant. Higher dud rates indicate a larger proportion of patents with no measurable downstream impact."},"terminal disclaimer":{term:"terminal disclaimer",definition:"A legal mechanism in which a patent owner voluntarily shortens a patent's term to match a related earlier patent, typically to overcome an obviousness-type double patenting rejection. Terminal disclaimers tie the enforceability of the later patent to the earlier one."},"prior art":{term:"prior art",definition:"Any evidence that an invention was already known before a patent application was filed. Includes earlier patents, published papers, products, and public demonstrations. Patent examiners cite prior art to assess novelty and non-obviousness."},"claim count":{term:"claim count",definition:"The total number of independent and dependent claims in a patent. Measures the scope of legal protection sought. Higher claim counts generally indicate broader or more detailed protection."},"continuation patent":{term:"continuation patent",definition:"A patent application filed by the same applicant that claims priority from an earlier (parent) application. Continuations allow applicants to pursue additional claims based on the same specification, often extending patent family protection over time."},"inter partes review":{term:"inter partes review",definition:"A trial proceeding at the Patent Trial and Appeal Board (PTAB) to challenge the validity of an issued patent based on prior art. Introduced by the America Invents Act (2011), IPR has become a major mechanism for patent challenges."},"patent portfolio":{term:"patent portfolio",definition:"The collection of all patents held by an entity (company, university, or individual). Portfolio analysis examines the technological breadth, citation impact, and strategic positioning of an organization's patent holdings."},"CPC section":{term:"CPC section",definition:"The broadest level of the Cooperative Patent Classification hierarchy, denoted by a single letter (A through H, plus Y). There are 8 primary sections (e.g., G = Physics, H = Electricity) and the cross-sectional tagging section Y."},"CPC class":{term:"CPC class",definition:"The second level of the CPC hierarchy, denoted by the section letter followed by two digits (e.g., G06 = Computing; Calculating). There are approximately 130 active CPC classes."},"CPC subclass":{term:"CPC subclass",definition:"The third level of the CPC hierarchy, denoted by the class code followed by one or more letters (e.g., G06N = Computing arrangements based on specific computational models). There are approximately 670 active CPC subclasses."}};function o(e){let{term:t,children:n}=e,[o,s]=(0,a.useState)(!1),l=(0,a.useCallback)(()=>s(!0),[]),c=(0,a.useCallback)(()=>{setTimeout(()=>s(!1),200)},[]),d=(0,a.useCallback)(e=>{"Escape"===e.key&&s(!1)},[]),h=r[t];if(!h)return(0,i.jsx)(i.Fragment,{children:null!=n?n:t});let m="glossary-".concat(t.replace(/\s+/g,"-").toLowerCase());return(0,i.jsxs)("span",{className:"relative inline",onMouseEnter:l,onMouseLeave:c,children:[(0,i.jsx)("span",{role:"term",tabIndex:0,"aria-describedby":m,onFocus:l,onBlur:c,onKeyDown:d,className:"cursor-help border-b border-dashed border-muted-foreground/50",children:null!=n?n:h.term}),(0,i.jsx)("span",{id:m,role:"tooltip",className:"absolute bottom-full left-1/2 z-50 mb-2 w-64 -translate-x-1/2 rounded-md border bg-card px-3 py-2 text-xs leading-relaxed text-foreground shadow-lg transition-opacity ".concat(o?"opacity-100":"opacity-0 pointer-events-none"),children:(0,i.jsx)("span",{className:"block text-muted-foreground",children:h.definition})})]})}},55407:function(e,t,n){"use strict";n.d(t,{_:function(){return a}});var i=n(57437);function a(e){let{value:t}=e;return(0,i.jsx)("span",{className:"font-semibold text-foreground bg-primary/5 px-1 rounded border-b-2 border-primary/20",children:t})}},96063:function(e,t,n){"use strict";n.d(t,{o:function(){return v}});var i=n(57437),a=n(2265),r=n(91436),o=n(77031),s=n(56940),l=n(97059),c=n(35794),d=n(62994),h=n(84962),m=n(78155),p=n(53250),u=n(64378),g=n(20407),f=n(24989),y=n(97254),b=n(50659);function v(e){let{data:t,xKey:n,bars:v,layout:x="horizontal",stacked:w=!1,colorByValue:A=!1,xLabel:P,yLabel:S,yFormatter:T,xDomain:j,showAvgLine:C=!1}=e,k="vertical"===x,[E,M]=(0,a.useState)(null),I=(0,a.useMemo)(()=>k?Math.min(260,Math.max(110,...t.map(e=>{var t;return 6.8*String(null!==(t=e[n])&&void 0!==t?t:"").length+16}))):10,[k,t,n]),R=(0,a.useMemo)(()=>{if(!C||0===v.length)return;let e=v[0].key,n=t.map(t=>Number(t[e])||0);return n.length>0?n.reduce((e,t)=>e+t,0)/n.length:void 0},[C,t,v]),F=(0,a.useMemo)(()=>{if(w)return[...v].reverse().map((e,t)=>{var n;let i=v.length-1-t;return{value:e.name,type:"circle",id:e.key,color:null!==(n=e.color)&&void 0!==n?n:f.ZE[i%f.ZE.length]}})},[v,w]),_=(0,a.useCallback)((e,t)=>M(t),[]),D=(0,a.useCallback)(()=>M(null),[]);return(0,i.jsx)(r.h,{width:"100%",height:"100%",children:(0,i.jsxs)(o.v,{data:t,layout:k?"vertical":"horizontal",margin:{top:5,right:10,left:k?I+10:10,bottom:5},barCategoryGap:k?"20%":"15%",children:[(0,i.jsx)(s.q,{strokeDasharray:"3 3",stroke:"hsl(var(--border))",opacity:.2,horizontal:!k,vertical:k}),k?(0,i.jsxs)(i.Fragment,{children:[(0,i.jsx)(l.K,{type:"number",tick:{fontSize:b.ZP.fontSize.tickLabel,fill:"hsl(var(--muted-foreground))",fontFamily:b.ZP.fontFamily},tickLine:!1,axisLine:{stroke:"hsl(var(--border))"},tickFormatter:null!=T?T:y.Py,domain:j,allowDataOverflow:!!j,ticks:j?[0,20,40,60,80,100]:void 0,children:S&&(0,i.jsx)(c.__,{value:S,position:"insideBottom",offset:-2,style:{fill:"hsl(var(--muted-foreground))",fontSize:b.ZP.fontSize.axisLabel,fontWeight:b.ZP.fontWeight.axisLabel,fontFamily:b.ZP.fontFamily}})}),(0,i.jsx)(d.B,{type:"category",dataKey:n,tick:{fontSize:b.ZP.fontSize.tickLabel,fill:"hsl(var(--muted-foreground))",fontFamily:b.ZP.fontFamily},tickLine:!1,axisLine:!1,width:I,interval:0,children:P&&(0,i.jsx)(c.__,{value:P,angle:-90,position:"insideLeft",style:{fill:"hsl(var(--muted-foreground))",fontSize:b.ZP.fontSize.axisLabel,fontWeight:b.ZP.fontWeight.axisLabel,fontFamily:b.ZP.fontFamily},offset:-5})}),void 0!==R&&(0,i.jsx)(h.db,{x:R,stroke:"#9ca3af",strokeDasharray:"4 4",label:{value:"Average",position:"top",fontSize:b.ZP.fontSize.tickLabel,fill:"#9ca3af"}})]}):(0,i.jsxs)(i.Fragment,{children:[(0,i.jsx)(l.K,{dataKey:n,tick:{fontSize:b.ZP.fontSize.tickLabel,fill:"hsl(var(--muted-foreground))",fontFamily:b.ZP.fontFamily},tickLine:!1,axisLine:{stroke:"hsl(var(--border))"},interval:0,angle:t.length>8?-35:0,textAnchor:t.length>8?"end":"middle",height:t.length>8?60:30,children:P&&(0,i.jsx)(c.__,{value:P,position:"insideBottom",offset:-2,style:{fill:"hsl(var(--muted-foreground))",fontSize:b.ZP.fontSize.axisLabel,fontWeight:b.ZP.fontWeight.axisLabel,fontFamily:b.ZP.fontFamily}})}),(0,i.jsx)(d.B,{tick:{fontSize:b.ZP.fontSize.tickLabel,fill:"hsl(var(--muted-foreground))",fontFamily:b.ZP.fontFamily},tickLine:!1,axisLine:!1,tickFormatter:null!=T?T:y.Py,width:60,children:S&&(0,i.jsx)(c.__,{value:S,angle:-90,position:"insideLeft",style:{fill:"hsl(var(--muted-foreground))",fontSize:b.ZP.fontSize.axisLabel,fontWeight:b.ZP.fontWeight.axisLabel,fontFamily:b.ZP.fontFamily},offset:-5})}),void 0!==R&&(0,i.jsx)(h.db,{y:R,stroke:"#9ca3af",strokeDasharray:"4 4",label:{value:"Average",position:"right",fontSize:b.ZP.fontSize.tickLabel,fill:"#9ca3af"}})]}),(0,i.jsx)(m.u,{contentStyle:f.sz,cursor:{fill:"hsl(var(--muted-foreground) / 0.08)"},formatter:(e,t)=>[T?T(Number(e)):(0,y.Py)(Number(e)),t]}),(0,i.jsx)(p.D,{wrapperStyle:{paddingTop:8,fontSize:b.ZP.fontSize.legend,fontFamily:b.ZP.fontFamily},iconType:"circle",iconSize:8,...F?{payload:F}:{}}),v.map((e,n)=>{var a;return(0,i.jsxs)(u.$Q,{dataKey:e.key,name:e.name,fill:null!==(a=e.color)&&void 0!==a?a:f.ZE[n%f.ZE.length],stackId:w?"stack":void 0,radius:k?[0,4,4,0]:[4,4,0,0],isAnimationActive:!1,onMouseEnter:_,onMouseLeave:D,children:[A&&t.map((e,t)=>(0,i.jsx)(g.b,{fill:f.ZE[t%f.ZE.length],fillOpacity:null!==E&&E!==t?.5:1},t)),!A&&t.map((e,t)=>(0,i.jsx)(g.b,{fillOpacity:null!==E&&E!==t?.7:1},t))]},e.key)})]})})}},86449:function(e,t,n){"use strict";n.d(t,{BF:function(){return o},Cm:function(){return h},D5:function(){return m},Ik:function(){return i},K4:function(){return u},Kc:function(){return p},Ns:function(){return c},QW:function(){return s},VT:function(){return l},W6:function(){return d},kM:function(){return g},ry:function(){return a},xz:function(){return r}});let i=[{x:1980,label:"Bayh-Dole Act",color:"#6366f1"},{x:1982,label:"Federal Circuit",color:"#6366f1"},{x:1995,label:"TRIPS Agreement",color:"#8b5cf6"},{x:1998,label:"State Street Bank",color:"#f59e0b"},{x:2e3,label:"AIPA",color:"#6366f1"},{x:2001,label:"Dot-com bust",color:"#ef4444"},{x:2007,label:"KSR v. Teleflex",color:"#f59e0b"},{x:2008,label:"Financial crisis",color:"#ef4444"},{x:2011,label:"America Invents Act",color:"#6366f1"},{x:2013,label:"AIA First-Inventor-to-File",color:"#6366f1"},{x:2014,label:"Alice Corp. decision",color:"#f59e0b"},{x:2017,label:"TC Heartland",color:"#f59e0b"},{x:2020,label:"COVID-19",color:"#ef4444"}],a=[{x:1997,label:"Kyoto Protocol",color:"#22c55e"},{x:2015,label:"Paris Agreement",color:"#22c55e"},{x:2022,label:"Inflation Reduction Act",color:"#6366f1"}],r=[{x:2e3,label:"Dot-com bust",color:"#ef4444"},{x:2011,label:"America Invents Act",color:"#6366f1"},{x:2022,label:"CHIPS Act",color:"#6366f1"}],o=[{x:2019,label:"Quantum supremacy",color:"#8b5cf6"},{x:2023,label:"Quantum error correction",color:"#8b5cf6"}],s=[{x:2013,label:"Snowden leaks",color:"#ef4444"},{x:2017,label:"WannaCry / GDPR",color:"#ef4444"},{x:2020,label:"SolarWinds hack",color:"#ef4444"}],l=[{x:1980,label:"Bayh-Dole Act",color:"#6366f1"},{x:2003,label:"Human Genome complete",color:"#8b5cf6"},{x:2012,label:"CRISPR published",color:"#22c55e"},{x:2020,label:"mRNA vaccines",color:"#22c55e"}],c=[{x:2009,label:"HITECH Act",color:"#6366f1"},{x:2020,label:"COVID-19 / telemedicine",color:"#ef4444"}],d=[{x:1996,label:"GM crops adopted",color:"#22c55e"},{x:2012,label:"Precision ag boom",color:"#22c55e"}],h=[{x:2009,label:"Google self-driving start",color:"#8b5cf6"},{x:2016,label:"Tesla Autopilot crash",color:"#ef4444"},{x:2020,label:"Waymo public launch",color:"#22c55e"}],m=[{x:2002,label:"SpaceX founded",color:"#8b5cf6"},{x:2015,label:"Falcon 9 landing",color:"#22c55e"},{x:2020,label:"Crew Dragon launch",color:"#22c55e"}],p=[{x:2009,label:"FDM patent expires",color:"#8b5cf6"},{x:2014,label:"Desktop 3D printing boom",color:"#22c55e"}],u=[{x:2008,label:"Bitcoin whitepaper",color:"#8b5cf6"},{x:2015,label:"Ethereum launch",color:"#8b5cf6"},{x:2021,label:"Crypto / NFT peak",color:"#ef4444"}];function g(e,t){let n=e;if(null==t?void 0:t.only){let e=new Set(t.only);n=n.filter(t=>e.has(t.x))}return(null==t?void 0:t.minX)!=null&&(n=n.filter(e=>e.x>=t.minX)),(null==t?void 0:t.maxX)!=null&&(n=n.filter(e=>e.x<=t.maxX)),n}}},function(e){e.O(0,[2972,917,553,1530,5736,894,6498,3796,2971,2117,1744],function(){return e(e.s=95533)}),_N_E=e.O()}]);